Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: The women's health initiative memory study

Journal of the American Geriatrics Society

Volumn 59, Issue 1, 2011, Pages 57-66

  Goveas, Joseph S ^a   Espeland, Mark A ^b   Woods, Nancy F ^c   Wassertheil Smoller, Sylvia ^d   Kotchen, Jane M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

cognitive decline; geriatric depression; mild cognitive impairment; probable dementia; women

Indexed keywords

ANTIDEPRESSANT AGENT;

AGED; ALGORITHM; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HORMONAL THERAPY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHIATRY; POSTMENOPAUSE; PROSPECTIVE STUDY; RISK ASSESSMENT; SOCIAL STATUS;

AGED; COGNITION DISORDERS; COMORBIDITY; DEMENTIA; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HUMANS; INCIDENCE; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 78651395988     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.03233.x     Document Type: Article

References (50)

1. Alzheimer's Association. Alzheimer's disease facts and figures. Alzheimers Dement 2009; 5: 234-270.
2. Roberts RO, Geda YE, Knopman DS, et al,. The Mayo Clinic Study of Aging: Design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology 2008; 30: 58-69.
3. Gauthier S, Reisberg B,; International Psychogeriatric Association Expert Conference on mild cognitive impairment et al. Mild cognitive impairment. Lancet 2006; 367: 1262-1270.
4. Steffens DC, Fisher GG, Langa KM, et al,. Prevalence of depression among older Americans: The Aging, Demographics and Memory Study. Int Psychogeriatr 2009; 21: 879-888.
5. Barnes DE, Alexopoulos GS, Lopez OL, et al,. Depressive symptoms, vascular disease, and mild cognitive impairment: Findings from the Cardiovascular Health Study. Arch Gen Psychiatry 2006; 63: 273-279.
6. Geda YE, Knopman DS, Mrazek DA, et al,. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: A prospective cohort study. Arch Neurol 2006; 63: 435-440.
7. Devanand DP, Sano M, Tang MX, et al,. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 1996; 53: 175-182.
8. Alexopoulos GS, Meyers BS, Young RC, et al,. The course of geriatric depression with "reversible dementia": A controlled study. Am J Psychiatry 1993; 150: 1693-1699.
9. Chen P, Ganguli M, Mulsant BH, et al,. The temporal relationship between depressive symptoms and dementia: A community-based prospective study. Arch Gen Psychiatry 1999; 56: 261-266.
10. Jorm AF., History of depression as a risk factor for dementia: An updated review. Aust N Z J Psychiatry 2001; 35: 776-781.
11. Wilson RS, Barnes LL, Mendes de Leon CF, et al,. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002; 59: 364-370.
12. Green RC, Cupples LA, Kurz A, et al,. Depression as a risk factor for Alzheimer disease: The MIRAGE Study. Arch Neurol 2003; 60: 753-759.
13. Wilson RS, Arnold SE, Beck TL, et al,. Change in depressive symptoms during the prodromal phase of Alzheimer disease. Arch Gen Psychiatry 2008; 65: 439-445.
14. Luchsinger JA, Honig LS, Tang MX, et al,. Depressive symptoms, vascular risk factors, and Alzheimer's disease. Int J Geriatr Psychiatry 2008; 23: 922-928.
15. Ownby RL, Crocco E, Acevedo A, et al,. Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006; 63: 530-538.
16. Panza F, D'Introno A., Italian Longitudinal Study on Aging Working Group. et al. Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian Longitudinal Study on Aging. Dement Geriatr Cogn Disord 2008; 25: 336-346.
17. Becker JT, Chang YF, Lopez OL, et al,. Depressed mood is not a risk factor for incident dementia in a community-based cohort. Am J Geriatr Psychiatry 2009; 17: 653-663.
18. Panza F, Capurso C, D'Introno A, et al,. Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging. Int J Geriatr Psychiatry 2008; 23: 726-734.
19. Fuhrer R, Dufouil C, Dartigues JF., PAQUID Study. Exploring sex differences in the relationship between depressive symptoms and dementia incidence: Prospective results from the PAQUID Study. J Am Geriatr Soc 2003; 51: 1055-1063.
20. Dal Forno G, Palermo MT, Donohue JE, et al,. Depressive symptoms, sex, and risk for Alzheimer's disease. Ann Neurol 2005; 57: 381-387.
21. Yaffe K, Blackwell T, Gore R, et al,. Depressive symptoms and cognitive decline in nondemented elderly women: A prospective study. Arch Gen Psychiatry 1999; 56: 425-430.
22. Rossouw JE, Anderson GL, Writing Group for the Women's Health Initiative Investigators et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.
23. Wassertheil-Smoller S, Hendrix SL, WHI Investigators et al. Effect of estrogen plus progestin on stroke in postmenopausal women: The Women's Health Initiative: A randomized trial. JAMA 2003; 289: 2673-2684.
24. Shumaker SA, Legault C, WHIMS Investigators et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. JAMA 2003; 289: 2651-2662.
25. Shumaker SA, Legault C, Women's Health Initiative Memory Study et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291: 2947-2958.
26. Shumaker SA, Reboussin BA, Espeland MA, et al,. The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 1998; 19: 604-621.
27. Anderson GL, Limacher M, Women's Health Initiative Steering Committee. et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701-1712.
28. Radloff LS., CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1997; 1: 385-401.
29. Robins LN, Helzer JE, Croughan J, et al,. National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry 1981; 38: 381-389.
30. Burnam MA, Wells KB, Leake B, et al,. Development of a brief screening instrument for detecting depressive disorders. Med Care 1988; 26: 775-789.
31. Borhani NO, Applegate WB, Cutler JA, et al,. Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and design. Hypertension 1991; 17: II2-II15.
32. Wassertheil-Smoller S, Shumaker S, Ockene J, et al,. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch Intern Med 2004; 164: 289-298.
33. Ainsworth BE, Haskell WL, Leon AS, et al,. Compendium of physical activities: Classification of energy costs of human physical activities. Med Sci Sports Exerc 1993; 25: 71-80.
34. Teng EL, Chui HC., The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987; 48: 314-318.
35. Morris JC, Heyman A, Mohs RC, et al,. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part I: Clinical and neuropsychological assessment of Alzheimer disease. Neurology 1989; 39: 1159-1165.
36. Reitan RM, Wolfson D., Conventional intelligence measurements and neuropsychological concepts of adaptive abilities. J Clin Psychol 1992; 48: 521-529.
37. Burke WJ, Roccaforte WH, Wengel SP., The short form of the Geriatric Depression Scale: A comparison with the 30-item form. J Geriatr Psychiatry Neurol 1991; 4: 173-178.
38. Spitzer RL, Williams JB, Kroenke K, et al,. Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study. JAMA 1994; 272: 1749-1756.
39. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, DC: American Psychiatric Association, 1994.
40. Petersen RC, Doody R, Kurz A, et al,. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-1992.
41. Ganguli M, Belle S, Ratclliff G, et al,. Sensitivity and specificity for dementia of population-based criteria for cognitive impairment: The MoVIES project. J Gerontol 1993; 48: M152-M161.
42. Wilson RS, Schneider JA, Boyle PA, et al,. Chronic distress and incidence of mild cognitive impairment. Neurology 2007; 68: 2085-2092.
43. Alexopoulos GS, Meyers BS, Young RC, et al,. 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997; 54: 915-922.
44. Steffens DC, Byrum CE, McQuoid DR, et al,. Hippocampal volume in geriatric depression. Biol Psychiatry 2000; 48: 301-309.
45. Bell-McGinty S, Butters MA, Meltzer CC, et al,. Brain morphometric abnormalities in geriatric depression: Long-term neurobiological effects of illness duration. Am J Psychiatry 2002; 159: 1424-1427.
46. Devanand DP, Pradhaban G, Liu X, et al,. Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease. Neurology 2007; 68: 828-836.
47. Butters MA, Klunk WE, Mathis CA, et al,. Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B. Alzheimer Dis Assoc Disord 2008; 22: 261-268.
48. Irie F, Masaki KH, Petrovitch H, et al,. Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: The Honolulu-Asia Aging Study. Arch Gen Psychiatry 2008; 65: 906-912.
49. Steffens DC, Otey E, Alexopoulos GS, et al,. Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry 2006; 63: 130-138.
50. Tuunainen A, Langer RD, Klauber MR, et al,. Short version of the CES-D (Burnam screen) for depression in reference to the structured psychiatric interview. Psychiatry Res 2001; 103: 261-270.